Concepedia

Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients

Martin G. Kees, Steven Weber, Frieder Kees, Thomas Horbach

Journal of Antimicrobial Chemotherapy · 2011 · 57 citations · 15 references

DOIFull text

Open access

Abstract

The pharmacokinetics of moxifloxacin is not significantly affected by morbid obesity. No dose adjustment seems to be necessary in this particular population.

References

15

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

Dagmar Kubitza · Journal of Antimicrobial Chemotherapy · 1999 · 248 citations

Dosing in Obesity: A Simple Solution to a Big Problem

Phey Yen Han, Stephen B. Duffull, Carl M. J. Kirkpatrick et al. · Clinical Pharmacology & Therapeutics · 2007 · 238 citations

, , +19

Adjustment of dosing of antimicrobial agents for bodyweight in adults

Matthew E. Falagas, Drosos E. Karageorgopoulos · The Lancet · 2009 · 132 citations

, , +11

Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing

UM Hollenstein, Martin Brunner, R. Schmid et al. · International Journal of Obesity · 2001 · 97 citations

, , +9

Intravenous ciprofloxacin disposition in obesity

S Allard, Martina Kinzig, Guy Boivin et al. · Clinical Pharmacology & Therapeutics · 1993 · 96 citations